Cannabis Report across cannabis plants

StockTalk | Cannabis Report: Shake-ups

MediPharm Labs announced that chief executive officer, David Pidduck will step down from his role, effective January...

Buzz on the Bullboards: As Arctic tensions flare, investors eye three news‑making stocks

Global markets opened the week on edge as a fresh rift between Washington and key NATO...

MediPharm Labs announces CEO transition as David Pidduck steps down

MediPharm Labs (TSX:LABS) CEO David Pidduck will step down on January 23, 2026, and will remain on the Board to support the transition.
Cannabis leaves with Stock Talk and Cannabis Report labels

StockTalk | Cannabis Report: New digs

Cannabis e-commerce company Herbal Dispatch (CSE:HERB) grew sales by 38 per cent in 2025, marking its third-straight year...

Cannabis e-commerce company Herbal Dispatch sees sales surge

Herbal Dispatch (CSE:HERB) grew sales by 38 per cent in 2025, marking its third-straight year of double-digit sales growth.
Cannabis Report image of farmed cannabis plants

StockTalk | Cannabis Report: Flocking South

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks

Curaleaf to relocate to the US amid improving regulatory sentiment

Curaleaf (TSX:CURA), one of the world's top cannabis companies, intends to redomicile from British Columbia to the US state of Delaware.

Buzz on the Bullboards: Energy shockwaves, market movers, and cross-border shifts

From geopolitical shocks in Venezuela to bold plays in fusion and cannabis, this week’s stories share a common thread ....
Stock Talk Cannabis Report image of cannabis plants and VW van

StockTalk | Cannabis Report: On the verge of U.S. reclassification?

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks
Cannabis leaves with Stock Talk and Cannabis Report labels

StockTalk | Cannabis Report: New stores, new shipments, new vapes

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks

Cronos Group buys Europe’s largest adult-use cannabis company

Cronos Group (TSX:CRON) will acquire Netherlands-based CanAdelaar, the largest adult-use cannabis company in Europe.
Cannabis Report above an image of cannabis

StockTalk | Cannabis Report: 2025 in review

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks

Buzz on the Bullboards: Cannabis stock split, major financing, and battery breakthrough

Inflation concerns, lofty valuations, and growing uncertainty around returns from have prompted investors to reassess their AI exposure.

What were some of the top cannabis stocks in 2025?

Canadian cannabis market hits record highs in 2025, with annual retail sales projected to exceed C$5.2 billion.
Cannabis Report text across cannabis leaves.

StockTalk | Cannabis Report: Black Friday? More like “Green Friday”

A top North American cannabis company signed an exclusive licensing agreement with Tyson 2.0, legendary boxer Mike...

TerrAscend and Mike Tyson team up on multi-state product launch

TerrAscend (TSX:TSND) signs an exclusive licensing agreement with Tyson 2.0, legendary boxer Mike Tyson's cannabis brand.
Cannabis Report across cannabis plants

StockTalk | Cannabis Report: Growing the product reach

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks

Canopy Growth expands Australian medical cannabis product suite

Canopy Growth adds new softgel capsules into the Australian market under its Spectrum Therapeutics medical cannabis brand.